The reduction of Dsg2 on the squamous cell carcinoma membrane increased the release of extracellular vesicles (EVs) containing EGFR and Src and that these EVs containing EGFR and Src can modulate the tumor microenvironment, a step critical for tumor progression [36]. The gene discussed is EGFR; the disease is squamous cell carcinoma.